Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime
Background & objectives: Insufficient treatment of cutaneous leishmaniasis (CL) by conventional drugs is a major barrier in control strategies. This study was aimed to evaluate Glucantime efficacy and the susceptibility of Glucantime unresponsive and responsive CL isolates in the field and labor...
Main Authors: | F Ezatkhah, I Sharifi, Z Babaei, M R Baneshi, F Zolala, A Kermanizadeh, A Keyhani, M Sharifi, E S Dezaki, M R Aflatoonian, B Aflatoonian, M Khatami, M Bamorovat |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Journal of Vector Borne Diseases |
Subjects: | |
Online Access: | http://www.jvbd.org/article.asp?issn=0972-9062;year=2019;volume=56;issue=4;spage=351;epage=359;aulast=Ezatkhah |
Similar Items
-
Comparison between intralesional glucantime injection and cryotherapy in papular cutaneous leishmaniasis
by: Yazdanpanah MJ, et al.
Published: (2006-10-01) -
Comparing the Effects of Topical Miltefosine and Glucantime in Treatment of Cutaneous Leishmaniasis
by: Ali Asilian, et al.
Published: (2014-03-01) -
Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
by: G Sadeghian, et al.
Published: (2011-01-01) -
The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
by: Abedin Saghafipour, et al.
Published: (2017-12-01) -
The Effect of Local Allergic Reaction to Intralesional Glucantime on Recovery Course of Cutaneous Leishmaniasis
by: Saman Afkhami-Ardakani, et al.
Published: (2020-04-01)